Cite

HARVARD Citation

    Emery, P. et al. (2016). Confirmation on the immunogenicity assay used in the SB4 phase III study: response to the comments by Meacci et al. Annals of the rheumatic diseases. 75 (7), p. e40. [Online]. 
  
Back to record